Evidence map›Paper›PMID 28011874›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2017

Activation of Nrf2 Reduces UVA-Mediated MMP-1 Upregulation via MAPK/AP-1 Signaling Cascades: The Photoprotective Effects of Sulforaphane and Hispidulin.

Anyamanee Chaiprasongsuk, Jinaphat Lohakul, Kitipong Soontrapa, Somponnat Sampattavanich, Pravit Akarasereenont, Uraiwan Panich

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Journal of microbiology and biotechnology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Research Progress in Skin Aging and Immunity.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anyamanee ChaiprasongsukDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Jinaphat LohakulDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kitipong SoontrapaDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Somponnat SampattavanichDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pravit AkarasereenontDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Uraiwan PanichDepartment of Pharmacology (A.C., J.L., K.S., S.S., P.A. and U.P.) and Center of Applied Thai Traditional Medicine, Faculty of Medicine (P.A.), Siriraj Hospital, Mahidol University, Bangkok, Thailand uraiwan.pan@mahidol.ac.th.
Mahidol University · THSiriraj Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UVA irradiation plays a role in premature aging of the skin through triggering oxidative stress-associated stimulation of matrix metalloproteinase-1 (MMP-1) responsible for collagen degradation, a hallmark of photoaged skin. Compounds that can activate nuclear factor E2-related factor 2 (Nrf2), a transcription factor regulating antioxidant gene expression, should therefore serve as effective antiphotoaging agents. We investigated whether genetic silencing of Nrf2 could relieve UVA-mediated MMP-1 upregulation via activation of mitogen-activated protein kinase (MAPK)/activator protein 1 (AP-1) signaling using human keratinocyte cell line (HaCaT). Antiphotoaging effects of hispidulin (HPD) and sulforaphane (SFN) were assessed on their abilities to activate Nrf2 in controlling MMP-1 and collagen expressions in association with phosphorylation of MAPKs (extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38), c-Jun, and c-Fos, using the skin of BALB/c mice subjected to repetitive UVA irradiation. Our findings suggested that depletion of Nrf2 promoted both mRNA expression and activity of MMP-1 in the UVA-irradiated HaCaT cells. Treatment of Nrf2 knocked-down HaCaT cells with MAPK inhibitors significantly suppressed UVA-induced MMP-1 and AP-1 activities. Moreover, pretreatment of the mouse skin with HPD and SFN, which could activate Nrf2, provided protective effects against UVA-mediated MMP-1 induction and collagen depletion in correlation with the decreased levels of phosphorylated MAPKs, c-Jun, and c-Fos in the mouse skin. In conclusion, Nrf2 could influence UVA-mediated MMP-1 upregulation through the MAPK/AP-1 signaling cascades. HPD and SFN may therefore represent promising antiphotoaging candidates.

Indexed as

Skin AgingAging, PrematureAnimalsAntimutagenic AgentsCell LineCollagenEnzyme ActivationFlavonesHumansIsothiocyanatesKeratinocytesMAP Kinase Signaling SystemMatrix Metalloproteinase 1MiceNF-E2-Related Factor 2Oxidative StressAntimutagenic AgentsCollagenFlavoneshispidulinIsothiocyanatesMatrix Metalloproteinase 1NF-E2-Related Factor 2sulforaphaneSulfoxidesTranscription Factor AP-1

Identifiers

PMID28011874
PMCPMC5325073
OpenAlexW2563575197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.